Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GroVida is a licensed pharmaceutical company and contract manufacturing organization (CMO) specializing in medical-grade cannabis cultivation and production for international pharmaceutical markets[1]. Operating one of Europe's largest medical cannabis cultivation facilities with 20,000 square meters of high-tech greenhouse space in Portugal's Algarve region, GroVida supplies GMP and GACP-accredited cannabis inflorescences and extracts to partners across the United Kingdom, European Union, and Australia[1][2]. The company is among Portugal's first licensed cannabis cultivators and leverages natural advantages including 300 days of annual sunshine while maintaining precise environmental controls[1]. Beyond cultivation, GroVida provides holistic supply chain management services, from bulk production to finished goods manufacturing[1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GroVida.